Nanthiya Sujijantarat

Dr. Nanthiya Sujijantarat

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in Stroke
Verified
Journal Article
Closed access
MMMercy H. Mazurek
Mercy H. Mazurek
NPNethra R. Parasuram
Nethra R. Parasuram
TPTeng Jiao Peng
Teng Jiao Peng
RBRachel Beekman
Rachel Beekman
VYVineetha Yadlapalli
Vineetha Yadlapalli
KSKevin N Sheth
Kevin N Sheth
BACKGROUND: Neuroimaging is essential for detecting spontaneous, nontraumatic intracerebral hemorrhage (ICH). Recent data suggest ICH can be characterized using low-field magnetic resonance imaging (MRI). Our primary objective was to investigate the sensitivity and specificity of ICH on a 0.064T portable MRI (pMRI) scanner using a methodology that provided clinical information to inform rater interpretations. As a secondary aim, we investigated whether the incorporation of a deep learning (DL) reconstruction algorithm affected ICH detection. METHODS: The pMRI device was deployed at Yale New Haven Hospital to examine patients presenting with stroke symptoms from October 26, 2020 to February 21, 2022. Three raters independently evaluated pMRI examinations. Raters were provided the images alongside the patient’s clinical information to simulate real-world context of use. Ground truth was the closest conventional computed tomography or 1.5/3T MRI. Sensitivity and specificity results were grouped by DL and non-DL software to investigate the effects of software advances. RESULTS: A total of 189 exams (38 ICH, 89 acute ischemic stroke, 8 subarachnoid hemorrhage, 3 primary intraventricular hemorrhage, 51 no intracranial abnormality) were evaluated. Exams were correctly classified as positive or negative for ICH in 185 of 189 cases (97.9% overall accuracy). ICH was correctly detected in 35 of 38 cases (92.1% sensitivity). Ischemic stroke and no intracranial abnormality cases were correctly identified as blood-negative in 139 of 140 cases (99.3% specificity). Non-DL scans had a sensitivity and specificity for ICH of 77.8% and 97.1%, respectively. DL scans had a sensitivity and specificity for ICH of 96.6% and 99.3%, respectively. CONCLUSIONS: These results demonstrate improvements in ICH detection accuracy on pMRI that may be attributed to the integration of clinical information in rater review and the incorporation of a DL-based algorithm. The use of pMRI holds promise in providing diagnostic neuroimaging for patients with ICH.

1 June 2023 in Stroke
Verified
Journal Article
Closed access
DRDaniela Renedo
Daniela Renedo
JAJulián N. Acosta
Julián N. Acosta
AKAndrew B. Koo
Andrew B. Koo
CRCyprien Rivier
Cyprien Rivier
Nanthiya SujijantaratNanthiya Sujijantarat
Nanthiya Sujijantarat
CMCharles C Matouk, MD
Charles C Matouk, MD
Background: Frailty is a prevalent state associated with several aging-related traits and conditions. The relationship between frailty and stroke remains understudied. Here we aim to investigate whether the hospital frailty risk score (HFRS) is associated with the risk of stroke and determine whether a significant association between genetically determined frailty and stroke exists. Design: Observational study using data from All of Us research program and Mendelian Randomization analyses. Methods: Participants from All of Us with available electronic health records were selected for analysis. All of Us began national enrollment in 2018 and is expected to continue for at least 10 years. All of Us is recruiting members of groups that have traditionally been underrepresented in research. All participants provided informed consent at the time of enrollment, and the date of consent was recorded for each participant. Incident stroke was defined as stroke event happening on or after the date of consent to the All of Us study HFRS was measured with a 3-year look-back period before the date of consent for stroke risk. The HFRS was stratified into 4 categories: no-frailty (HFRS=0), low (HFRS ≥1 and <5), intermediate (≥5 and <15), and high (HFRS ≥15). Last, we implemented Mendelian Randomization analyses to evaluate whether genetically determined frailty is associated with stroke risk. Results: Two hundred fifty-three thousand two hundred twenty-six participants were at risk of stroke. In multivariable analyses, frailty status was significantly associated with risk of any (ischemic or hemorrhagic) stroke following a dose-response way: not-frail versus low HFRS (HR, 4.9 [CI, 3.5–6.8]; P <0.001), not-frail versus intermediate HFRS (HR, 11.4 [CI, 8.3–15.7]; P <0.001) and not-frail versus high HFRS (HR, 42.8 [CI, 31.2–58.6]; P <0.001). We found similar associations when evaluating ischemic and hemorrhagic stroke separately ( P value for all comparisons <0.05). Mendelian Randomization confirmed this association by indicating that genetically determined frailty was independently associated with risk of any stroke (OR, 1.45 [95% CI, 1.15–1.84]; P =0.002). Conclusions: Frailty, based on the HFRS was associated with higher risk of any stroke. Mendelian Randomization analyses confirmed this association providing evidence to support a causal relationship.

1 November 2024 in Stroke: Vascular and Interventional Neurology
Verified
Journal Article
Open access
Nanthiya SujijantaratNanthiya Sujijantarat
Nanthiya Sujijantarat
KTKelsey A. Templeton
Kelsey A. Templeton
JAJoseph P. Antonios
Joseph P. Antonios
DRDaniela Renedo
Daniela Renedo
AKAndrew B. Koo
Andrew B. Koo
CMCharles C Matouk, MD
Charles C Matouk, MD
Background: Prior studies have suggested an association between clot histological composition and cause of stroke. However, the results have been conflicting. Our objective is to provide an updated systematic review and meta‐analysis of the association between clot histological composition and cause of stroke for patients who underwent mechanical thrombectomy. Methods: We searched Cochrane Library, Embase, and MEDLINE databases for English language articles reporting clot histology in adult patients who underwent mechanical thrombectomy for acute ischemic stroke between January 2000 and March 2024. Studies included reported on the association between causes of clots and the quantity of red blood cells and fibrin and/or platelets. Random effects meta‐analysis was used. Results: A total of 448 records were identified. Of these, 25 studies were included in the qualitative synthesis, and 17 contained data in a format suitable for quantitative review. A total of 1656 patients had continuous data on clot composition and its association with cause of stroke. The pooled mean percentage difference between the cardioembolic group and the large artery atherosclerosis /noncardioembolic group was −10.3% (95% CI −16.3% to −4.4%) for red blood cells and +9.9% (95% CI +4.5% to +15.4%) for fibrin and/or platelets. Only 7 studies reported on overall white blood cells quantity. Of these, the pooled percentage difference of white blood cells between the cardioembolic group and the large artery atherosclerosis/non‐cardioembolic group was +1.1% (95% CI +0.3% to +1.9%). Conclusion: Our results suggest that cardioembolic clots have higher fibrin and/or platelets and lower red blood cells compared with large artery atherosclerosis/noncardioembolic clots. However, these differences are unlikely to be of clinical utility in differentiating cause of stroke. Future studies would benefit from more rigorous analysis of clot constituents beyond cellular composition.

Verified
Journal Article
Open access
PDF file
BTBen Teasdale
Ben Teasdale
EOEdwin Owolo
Edwin Owolo
VPVarun Padmanaban
Varun Padmanaban
Aladine A. ElsamadicyAladine A. Elsamadicy
Aladine A. Elsamadicy
AAAbdelaziz Amllay
Abdelaziz Amllay
Nanthiya SujijantaratNanthiya Sujijantarat
Nanthiya Sujijantarat
Vertebral artery injury (VAI) is a known complication of blunt cervical spine trauma with a potential risk of stroke. Factors including cervical bony injury, spinal cord injury, and overall trauma severity have been linked to an increased risk of VAI. Despite its prevalence, there is little consensus on various aspects of this pathology, including its initial screening, diagnostic approaches, and therapeutic strategies. A recent systematic review and meta-analysis from our group highlighted the dynamic nature of vertebral artery occlusion, revealing the underrecognized recanalization rates and potential stroke risks associated with delayed recanalization. While anticoagulant and/or antiplatelet therapy (ACAP) remains the cornerstone of VAI management, treatment is often complicated by co-existing injuries, such as intracranial hemorrhage or cervical trauma, which may preclude or delay ACAP usage or necessitate surgical intervention. This comprehensive narrative review synthesizes the latest evidence on VAI and associated ischemic sequelae, with the goal of elucidating its pathophysiology and natural history, summarizing current data on screening and diagnosis, and exploring key considerations for medical and endovascular management.

1 December 2017 in World Neurosurgery
Verified
Journal Article
Closed access
Nanthiya SujijantaratNanthiya Sujijantarat
Nanthiya Sujijantarat
MPMatthew J. Pierson
Matthew J. Pierson
JKJoanna Kemp
Joanna Kemp
JCJeroen R. Coppens
Jeroen R. Coppens

2 September 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
DRDaniela Renedo
Daniela Renedo
TBTanyeri Barak
Tanyeri Barak
JDJonathan DeLong
Jonathan DeLong
JAJulian N. Acosta
Julian N. Acosta
Nanthiya SujijantaratNanthiya Sujijantarat
Nanthiya Sujijantarat
CMCharles C Matouk, MD
Charles C Matouk, MD
Background: Ischemic stroke results in significant morbidity and mortality. By examining gene expression of cells comprising stroke clots, we aim to gain valuable insights into the underlying mechanisms of this disease and identify potential biomarkers of stroke cause. Methods: We employed single‐cell RNA sequencing to analyze 10 clot samples from patients diagnosed with large vessel occlusion stroke. We aimed to identify and compare the immune cell compositions and gene expression profiles between stroke clots (atrial fibrillation vs carotid atherosclerosis). We also used Multi‐marker Analysis of Genomic Annotation and genome‐wide association studies summary statistics from the GIGASTROKE consortium to assess associations between genetic variants and cell type‐specific gene expression within the stroke subtypes. Results: Our analysis revealed distinct immune cell populations, including monocytes, macrophages, dendritic cells, neutrophils, and T cells in both clot types. Notably, we observed significant differences in gene expression within the mononuclear phagocytic system cells between clots from patients with atrial fibrillation and carotid atherosclerosis. We identified specific genes associated with atherosclerosis and stroke‐related processes, such as CD74, HLA‐DRB1*01, HTRA1, C1Q, CD81 , and CR1 from patients with carotid atherosclerosis. In atrial fibrillation clots, CD8 T cells and natural killer cells show upregulated expression of genes such as GZMH , GZMB , S100A4 , FCGBP2 , HLA‐A , TIMP1 , CLIC1 , and IFITM2 , indicating their involvement in cytotoxic activities and potential tissue damage. The Multi‐marker Analysis of Genomic Annotation approach highlighted significant genetic associations within leukocytes underscoring the potential roles of B cells, T cells, and macrophages in clot pathogenesis. Conclusions: This study illuminates the immune and transcriptomic landscape within clots, offering potential biomarkers and lays the foundation for future research.